首页/数据集/ctDNA RaDaR data for all 445 time points for all 130 LEMA patients.

ctDNA RaDaR data for all 445 time points for all 130 LEMA patients.

Figshare2025-04-15 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/ctDNA_RaDaR_data_for_all_445_time_points_for_all_130_LEMA_patients_/28799350 数据链接链接失效反馈

官方服务：

资源简介：

ctDNA RaDaR data for all 445 time points for all 130 LEMA patients.

应用场景：

创建时间：

2025-04-15

循环肿瘤DNA

市场分析

North America Circulating Tumor DNA (ctDNA) comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to foreca

IMR REPORTS70

Supplementary Table S7 from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

循环肿瘤DNA

卵巢癌基因

List of genes encoded on cytoband 11q13.3, within the significant focal region identified by GISTIC

NIAID Data Ecosystem40

DataSheet_1_Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML.zip

急性髓系白血病NPM1突变检测

微小残留病

BackgroundNPM1 mutation status can influence prognosis and management in AML. Accordingly, clinical testing (i.e., RT-PCR, NGS and IHC) for mutant NPM1 is increasing in order to detect residual diseas

NIAID Data Ecosystem30

DataSheet_2_Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients.xlsx

结直肠癌基因组学

循环肿瘤DNA

BackgroundColorectal cancer (CRC) is the fifth most common cancer with rising prevalence in Vietnam. However, there is no data about the mutational landscape and actionable alterations in the Vietname

NIAID Data Ecosystem50

Integrated analysis of genomic and epigenomic alterations in circulating tumor DNA in patients with colorectal cancer and advanced adenoma

结直肠癌诊断

循环肿瘤DNA

Primary outcome(s): Positive rate of LUNAR assay in advanced colorectal adenoma and stage 0-2 colorectal cancer.

NIAID Data Ecosystem30